It was supposed to be a battle over high drug prices, but right now, it’s become a battle over transparency — specifically, which drug makers are funding an effort to block a measure on the ballot in Ohio this November that seeks to rein in drug prices in the state.
The proposal in Ohio is similar to the one that California voters shot down last November following a huge oppositional push from drug companies; it’s even backed by the same group, the AIDS Healthcare Foundation, which runs a nonprofit network of clinics.
About the Author Reprints
